| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1.0 | 0.7 |
| Gross profit | 0.3 | 0.2 |
| Net income | -2.3 | -1.8 |
| EPS (diluted, $ a share) | $-0.27 | $-0.38 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +51.1% |
|---|---|
| Gross margin | 31.8% |
10-Q filed with the SEC, NASDAQ: LUCY. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Innovative Eyewear Inc: key numbers
- Share price
- $0.7820Close, Nov 16
- Market cap
- $6.81M
- Shares outstanding
- 8.71MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Ophthalmic GoodsSIC 3851
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Innovative Eyewear Inc
All →Innovative Eyewear Nasdaq/NYSE Compliance Notice
Innovative Eyewear received a deficiency notice from Nasdaq on October 9, 2026, because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until April 7, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
- Counterparty
- The Nasdaq Stock Market LLC
- Term
- 180 days
Innovative Eyewear Business Update
Innovative Eyewear reported preliminary Q3 2026 net sales of approximately $1.04 million, representing 55% year-over-year growth and the company's highest quarterly revenue to date. The company also announced major wholesale and international expansions, including a rollout in over 150 U.S. big-box retail stores and a 345-location launch in Canada with FYihealth Group.
- Term
- Q3 2026